CORT vs. COST
Compare and contrast key facts about Corcept Therapeutics Incorporated (CORT) and Costco Wholesale Corporation (COST).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CORT or COST.
Key characteristics
| CORT | COST | |
|---|---|---|
| YTD Return | 19.67% | 38.07% |
| 1Y Return | 16.13% | 67.85% |
| 3Y Return (Ann) | 23.61% | 27.03% |
| 5Y Return (Ann) | 23.63% | 27.74% |
| 10Y Return (Ann) | 30.65% | 24.45% |
| Sharpe Ratio | 0.27 | 3.33 |
| Daily Std Dev | 55.36% | 19.60% |
| Max Drawdown | -94.28% | -70.95% |
| Current Drawdown | 0.00% | -0.95% |
Fundamentals
| CORT | COST | |
|---|---|---|
| Market Cap | $3.98B | $406.09B |
| EPS | $1.13 | $16.11 |
| PE Ratio | 33.73 | 56.86 |
| PEG Ratio | 0.61 | 5.69 |
| Total Revenue (TTM) | $569.61M | $174.76B |
| Gross Profit (TTM) | $561.03M | $21.99B |
| EBITDA (TTM) | $129.11M | $6.76B |
Correlation
The correlation between CORT and COST is 0.16, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CORT vs. COST - Performance Comparison
In the year-to-date period, CORT achieves a 19.67% return, which is significantly lower than COST's 38.07% return. Over the past 10 years, CORT has outperformed COST with an annualized return of 30.65%, while COST has yielded a comparatively lower 24.45% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CORT vs. COST - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Corcept Therapeutics Incorporated (CORT) and Costco Wholesale Corporation (COST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CORT vs. COST - Dividend Comparison
CORT has not paid dividends to shareholders, while COST's dividend yield for the trailing twelve months is around 2.13%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
COST Costco Wholesale Corporation | 2.13% | 2.87% | 0.76% | 0.54% | 3.38% | 0.86% | 1.08% | 4.81% | 1.09% | 4.06% | 0.97% | 1.01% |
Drawdowns
CORT vs. COST - Drawdown Comparison
The maximum CORT drawdown since its inception was -94.28%, which is greater than COST's maximum drawdown of -70.95%. Use the drawdown chart below to compare losses from any high point for CORT and COST. For additional features, visit the drawdowns tool.
Volatility
CORT vs. COST - Volatility Comparison
Corcept Therapeutics Incorporated (CORT) has a higher volatility of 8.97% compared to Costco Wholesale Corporation (COST) at 5.30%. This indicates that CORT's price experiences larger fluctuations and is considered to be riskier than COST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CORT vs. COST - Financials Comparison
This section allows you to compare key financial metrics between Corcept Therapeutics Incorporated and Costco Wholesale Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities